Kevin C. Tang
2020
In 2020, Kevin C. Tang earned a total compensation of $1 as Chairman and Chief Executive Officer at Odonate Therapeutics, which was the same as previous year.
Compensation breakdown
| Salary | $1 |
|---|---|
| Total | $1 |
Tang received $1 in salary, accounting for 100% of the total pay in 2020.
Rankings
In 2020, Kevin C. Tang's compensation ranked 13,088th out of 13,090 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,088 out of 13,090 | 0th |
Division Manufacturing | 5,621 out of 5,621 | 0th |
Major group Chemicals And Allied Products | 2,254 out of 2,254 | 0th |
Industry group Drugs | 1,954 out of 1,954 | 0th |
Industry Pharmaceutical Preparations | 1,459 out of 1,459 | 0th |
Source: SEC filing on June 1, 2021.
Tang's colleagues
We found two more compensation records of executives who worked with Kevin C. Tang at Odonate Therapeutics in 2020.
News
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
June 1, 2021
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
May 15, 2020
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
June 24, 2019